ReadYourDNA

Symdeko

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Symdeko

What it is

Tezacaftor/ivacaftor is a combination CFTR modulator for cystic fibrosis: tezacaftor helps faulty CFTR protein reach the cell surface, and ivacaftor holds its channel open. It is used for people with two copies of F508del or with one of several residual-function CFTR variants, and causes fewer interactions than lumacaftor/ivacaftor. It is sold as Symdeko and Symkevi.

How genes come into it

Whether it works depends on CFTR, the gene behind cystic fibrosis: it is approved for people homozygous for F508del (rs113993960), a finding rated at PharmGKB's highest level, and for listed residual-function variants. Both parts are broken down by CYP3A4. There is no CPIC or DPWG guideline for the combination.

What research found

Every published finding on gene variants and Symdeko. Upload your DNA file to see which of these rows apply to you.

Rated evidence (1 rated variant)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

CFTR rs113993960: Level 1A · replicated. Efficacy: Cystic Fibrosis. 3.

Response (1 finding)

Studies of how well it worked in people carrying a variant.

CFTR rs75389940: Genotypes AG + GG is associated with increased clinical benefit to elexacaftor / tezacaftor / ivacaftor or ivacaftor / tezacaftor in people with Cystic Fibrosis.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Kalydeco (CFTR Modulators)

Lumacaftor (CFTR Modulators)

Orkambi (CFTR Modulators)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com